Examining Hepatitis C Virus Treatment Access:
A Review of Select State Medicaid Fee-For-Service and Managed Care Programs
Thursday, April 2, 2015
3:00 – 4:30 PM EST (2:00 – 3:30 PM CST/12:00 – 1:30 PM PST)
The arrival of an HCV cure is an exciting development for the millions of Americans who suffer from HCV. However, the high cost of treatment has led many Medicaid programs across the country to implement treatment access restrictions. The restrictions unfairly limit access and are not based on clinical evidence. Action must be taken!
Join the Center for Health Law and Policy Innovation of Harvard Law School, the National Viral Hepatitis Roundtable, and HIV Health Reform to learn about a new report that analyzes treatment access restrictions in Medicaid fee-for-service and managed care programs across 10 states. Learn how you can utilize this tool to expand access to the cure in your state.
We look forward to launching this new resource and answering your questions.
- Robert Greenwald Director, Center for Health Law and Policy Innovation; Clinical Professor of Law, Harvard Law School
- Kellen Wittkop Harvard Law School
- Ryan Clary Executive Director, National Viral Hepatitis Roundtable
- Michael Ninburg Executive Director, Hepatitis Education Project
The report was developed by the Center for Health Law & Policy Innovation of Harvard Law School with support from the National Viral Hepatitis Roundtable.